Literature DB >> 15305013

Secretory phospholipase A2.

Makoto Murakami1, Ichiro Kudo.   

Abstract

Secretory phospholipase A2 (sPLA2) is a growing family of structurally related, disulfide-rich, low molecular weight, lipolytic enzymes with a His-Asp catalytic dyad. sPLA2s are distributed in a wide variety of vertebrate and invertebrate animals, plants, bacteria, and viruses, and there are 10 catalytically active sPLA2 isozymes in mammals. Although the structural bases for mammalian sPLA2s have been well documented, their physiological functions are still subject to debate. Individual mammalian sPLA2s have distinct enzymatic properties and display distinct tissue expression patterns, suggesting that each enzyme acts on distinct phospholipid membrane moieties in vivo. In this article, we briefly review our latest understanding of the possible physiological functions of sPLA2s, in keeping with their diverse actions on mammalian and nonmammalian cell membranes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15305013     DOI: 10.1248/bpb.27.1158

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  28 in total

1.  Effect of NGF on the subcellular localization of group IIA secretory phospholipase A(2) (GIIA) in PC12 cells: role in neuritogenesis.

Authors:  M Ferrini; V Nardicchi; R Mannucci; C Arcuri; I Nicoletti; R Donato; G Goracci
Journal:  Neurochem Res       Date:  2010-12-02       Impact factor: 3.996

Review 2.  Meconium-induced inflammation and surfactant inactivation: specifics of molecular mechanisms.

Authors:  Jana Kopincova; Andrea Calkovska
Journal:  Pediatr Res       Date:  2015-12-17       Impact factor: 3.756

3.  The pleiotropic vegetative and sexual development phenotypes of Neurospora crassa arise from double mutants of the calcium signaling genes plc-1, splA2, and cpe-1.

Authors:  Ananya Barman; Ranjan Tamuli
Journal:  Curr Genet       Date:  2017-03-06       Impact factor: 3.886

4.  Inhibitory effects of bile acids on enzymatic and pharmacological activities of a snake venom phospholipase A(2) from group IIA.

Authors:  Jaime Andrés Pereañez; Vitelbina Núñez; Arley Camilo Patiño
Journal:  Protein J       Date:  2011-04       Impact factor: 2.371

5.  Scalable generation of high-titer recombinant adeno-associated virus type 5 in insect cells.

Authors:  Masashi Urabe; Takayo Nakakura; Ke-Qin Xin; Yoko Obara; Hiroaki Mizukami; Akihiro Kume; Robert M Kotin; Keiya Ozawa
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

Review 6.  Multiple roles of phospholipase A2 during lung infection and inflammation.

Authors:  Bryan P Hurley; Beth A McCormick
Journal:  Infect Immun       Date:  2008-04-14       Impact factor: 3.441

7.  Chronic intracerebroventricular delivery of the secretory phospholipase A2 inhibitor, 12-epi-scalaradial, does not improve outcome after focal cerebral ischemia-reperfusion in rats.

Authors:  Germán Torregrosa; Fernando J Pérez-Asensio; María C Burguete; María Castelló-Ruiz; Juan B Salom; Enrique Alborch
Journal:  Exp Brain Res       Date:  2007-01       Impact factor: 1.972

8.  Disruption of group IVA cytosolic phospholipase A(2) attenuates myocardial ischemia-reperfusion injury partly through inhibition of TNF-α-mediated pathway.

Authors:  Yukio Saito; Kazuhiro Watanabe; Daisuke Fujioka; Takamitsu Nakamura; Jun-ei Obata; Kenichi Kawabata; Yosuke Watanabe; Hideto Mishina; Shun Tamaru; Yoshihiro Kita; Takao Shimizu; Kiyotaka Kugiyama
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-16       Impact factor: 4.733

Review 9.  G2A and LPC: regulatory functions in immunity.

Authors:  Janusz H Kabarowski
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-04-19       Impact factor: 3.072

Review 10.  Calcium-independent phospholipases in the heart: mediators of cellular signaling, bioenergetics, and ischemia-induced electrophysiologic dysfunction.

Authors:  Ari Cedars; Christopher M Jenkins; David J Mancuso; Richard W Gross
Journal:  J Cardiovasc Pharmacol       Date:  2009-04       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.